This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Ucb Holdings, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Petra Duda - Innovator in Neurological Treatments
Introduction
Petra Duda is an accomplished inventor based in Charlestown, MA (US). She is currently associated with Ra Pharmaceuticals, Inc. Petra has made significant contributions to the field of neurological disease treatment, particularly focusing on myasthenia gravis.
Latest Patent Applications
Petra Duda's latest patent applications include:
1. **Treatment of Myasthenia Gravis with Zilucoplan** - This application provides methods of using zilucoplan as a therapy for AChR positive generalized myasthenia gravis (gMG) patients who have gMG refractory to conventional immunosuppressive therapy and/or intravenous (IV) immunoglobulin and plasma exchange (PLEX) therapy.
2. **Neurological Disease Treatment with Zilucoplan** - This application includes methods of treating myasthenia gravis, including generalized myasthenia gravis, by providing C5 complement inhibitors. It also includes devices and kits for inhibitor administration and methods of evaluating complement inhibitor treatment efficacy.
Conclusion
Petra Duda is a notable inventor whose work is paving the way for innovative treatments in neurological diseases. Her dedication to advancing medical therapies is evident in her latest patent applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile